Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASTRRA: OFS + Tamoxifen in Breast Cancer
NCT00912548Phase 3Unknown
- Sponsor
- Korean Breast Cancer Study Group
- Start
- May 2009
- Primary completion
- Dec 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of goserelin in Hormone-Receptor-Positive Breast Cancer, sponsored by Korean Breast Cancer Study Group. Status: unknown.
02
Drugs
goserelin
03
Conditions
Hormone-Receptor-Positive Breast Cancer
Beyond the preview
Go deeper on NCT00912548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00912548.